Concourse Financial Group Securities, Inc. Mirum Pharmaceuticals, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.67 Billion
Q4 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share
Q4 2024 Feb 13, 2025	BUY	$37.85 - $46.65 $0 - $0
Q3 2024 Oct 10, 2024	BUY	$33.68 - $44.74 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$23.57 - $34.85 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$24.92 - $30.02 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$27.14 - $34.93 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$24.63 - $32.85 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$24.63 - $32.85 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$23.51 - $30.09 $0 - $0
Q1 2023 May 15, 2023	BUY	$19.19 - $24.1 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$17.59 - $23.83 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$19.98 - $29.44 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$18.42 - $27.5 $0 - $0
Q1 2022 May 09, 2022	BUY	$15.5 - $23.93 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$13.05 - $19.35 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$13.95 - $20.18 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$15.84 - $20.6 $0 - $0
Q1 2021 May 13, 2021	BUY	$16.29 - $21.92 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$15.75 - $25.45 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$18.4 - $26.59 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$11.51 - $20.97 $0 - $0
Q1 2020 May 13, 2020	BUY	$9.38 - $23.79 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$6.84 - $25.9 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$9.16 - $14.77 $0 - $0

Others Institutions Holding MIRM

# of Institutions

211

Shares Held

53.8M

Call Options Held

2.6K

Put Options Held

99.7K

Frazier Life Sciences Management, L.P. Menlo Park, CA

6.57M
Shares

$313 Million
16.29% of portfolio
Janus Henderson Group PLC London, X0

4.58M
Shares

$218 Million
0.1% of portfolio
Black Rock Inc. New York, NY

3.24M
Shares

$154 Million
0.0% of portfolio
Bvf Inc San Francisco, CA

2.8M
Shares

$133 Million
4.33% of portfolio
Eventide Asset Management, LLC Boston, MA

2.61M
Shares

$124 Million
2.07% of portfolio

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.75B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account